SAINTVILUS ON TECH STOCKS

Valeant Pharmaceuticals International Inc (VRX)

NYSE: Health Care

$47.92

-0.48 | -0.99%

Today's Range: 47.15 - 48.17

VRX Avg. Daily Volume: 1,774,700

05/30/12 - 4:03 PM ET

TRADE NOW

Insider Trading

Historical Data	Current	1 Mo. Ago	2 Mo. Ago	3 Mo. Ago	4 Mo. Ago	5 Mo. Ago	6 Mo. Ago

Net Insider Transaction	24,599	-545	51,394	184,192	181,936	399,521	291,331
Shares Bought	102,622	112,355	114,755	235,189	181,936	399,521	291,331
Shares Sold	78,023	112,900	63,361	50,997	0	0	0

Institutional Trading

Historical Data	Current	1 Mo. Ago	2 Mo. Ago	3 Mo. Ago	4 Mo. Ago	5 Mo. Ago	6 Mo. Ago

Total Shares Held	279.09M	275.24M	283.47M	279.88M	277.10M	277.10M	277.07M
Shares Bought	38.43M	35.08M	34.81M	28.52M	62.25M	62.25M	62.27M
Shares Sold	26.14M	30.33M	28.43M	30.52M	39.46M	39.46M	41.39M

Latest VRX Headlines

More Financial News for VRX

Press Releases for VRX

Valeant Pharmaceuticals To Syndicate Incremental Term Loans - PR Newswire
Valeant Pharmaceuticals Agrees To Acquire Certain Assets From Swiss Herbal - PR Newswire
Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical - PR Newswire
Valeant Pharmaceuticals To Announce 2012 First Quarter Results On May 3, 2012 - PR Newswire
Valeant Pharmaceuticals To Acquire Pedinol - PR Newswire
Dr. LeWinn By KineraseÂ® Earns Four Good Housekeeping Seals - PR Newswire
Valeant To Move Its Global Head Office To Quebec And Establish A New Center Of Excellence In Dermatology - PR Newswire
Valeant Pharmaceuticals Agrees To Acquire Natur Produkt In Russia - PR Newswire
Valeant Pharmaceuticals Agrees To Acquire Certain Assets From Gerot Lannach - PR Newswire
Valeant Pharmaceuticals Acquires A 19.9% Minority Equity Investment In Biotech Company In Brazil - PR Newswire

See all press releases.

Refresh Stock Quote for Valeant Pharmaceuticals International Inc - VRX

TheStreet Premium Services

Compare All Services

Jim Cramer's Action Alerts PLUS:

Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More

OptionsProfits:

Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More

Real Money:

Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More

Stocks Under $10:

Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More

Dow Jones	S&P 500	NASDAQ	10-Year Note
12,419.86	1,313.32	2,837.36	16.25	Oil * 103.00
DOWN 160.83	DOWN 19.10	DOWN 33.63	DOWN 1.06	10 Yr 1.62% SPDR Gold 151.91
-1.28%	-1.43%	-1.17%	-6.12%	Data delayed 20 minutes

Free Newsletters from TheStreet

We respect your privacy.

Manage Newsletters

Podcasts

Daily RSS Updates

TheStreet Mobile Edition

Connect with TheStreet